MedTrace Logo

Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial

NCT05314725 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-04-06

No results posted yet for this study

Summary

The aim of the study is to investigate the effect of an SGLT-2 inhibitor on postoperative hyperglycemia after acute abdominal surgery in patients without diabetes

Conditions

  • Postoperative Hyperglycemia
  • Stress Hyperglycemia

Interventions

DRUG

SGLT2 inhibitor

10 days of SGLT2 inhibitor after surgery

DRUG

Placebo

10 days of placebo after surgery

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Emilie P Palmgren Colov · Zealand University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-05-01
Completion
2023-06-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314725 on ClinicalTrials.gov